Answers are grounded in this paper and cite their sources.
Integration of spatial and single-cell transcriptomics identifies PAK2 in idiopathic pulmonary fibrosis, suggesting therapeutic opportunities.
Extract We read with great interest the article by Watanabe et al. [1], which integrates spatial and single-cell transcriptomics to identify a WNT5A⁺CTHRC1⁺ myofibroblast subset and implicates p21-activated kinase 2 (PAK2) activation as a potential therapeutic driver in idiopathic pulmonary fibrosis (IPF). As spatial multi-omics technologies reshape our understanding of fibrotic microenvironments, defining cell-specific causal pathways and clinically actionable targets has become a central challenge in translational respiratory research.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: